NEW YORK (Reuters Health) – An “important” relation exists between platelet reactivity and glycemic control in patients with type 2 diabetes and coronary artery disease who are on…
NEW YORK (Reuters Health) – New research confirms that tubular carcinoma (TC) of the breast has an excellent prognosis and goes on to show that outcomes are better…
NEW YORK (Reuters Health) – Transfusion of two rather than one unit of partially HLA-matched umbilical cord blood (UCB) appears to reduce the risk of relapse in leukemia…
NEW YORK (Reuters Health) – Cervical cancer screening should begin when a woman turns 21, according to newly revised evidence-based guidelines issued November 20 by the American College…
NEW YORK (Reuters Health) – The initial empiric antimicrobial therapy used to treat septic shock may be the most important determinant of whether a patient will survive to…
NEW YORK (Reuters Health) – In a study of living donor liver transplantations with left side grafts, no significant difference in survival was seen when grafts
NEW YORK (Reuters Health) – Use of erythropoiesis-stimulating agents in US cancer patients undergoing chemotherapy has increased 10-fold since their introduction, yet there’s been no associated decline in…
NEW YORK (Reuters Health) – Lipid assessment of vascular disease risk can be simplified by measuring either cholesterol levels or apolipoproteins, without fasting and without looking at triglyceride…
NEW YORK (Reuters Health) – Blood transfusion is safe and may be beneficial in patients with acute decompensated heart failure, say researchers from Israel in the October American…
NEW YORK (Reuters Health) – In women treated for small (1 cm or less), node-negative breast cancers, HER2 positivity is strongly linked to recurrence and poorer disease-free survival,…
